- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06336122
OASIS: Peer Support for T2DM in Appalachia (Peer Participant) (OASIS)
Older Adults Using Social Support to Improve Self-Care: Adaptation, Implementation, and Feasibility of Peer Support for Older Adults With T2DM in Appalachia.
The goal of this clinical trial is to compare the effects of peer coaching models in older adults with unmanaged type two diabetes. The main questions it aims to answer are:
Are peer coaching models effective at promoting Type 2 Diabetes Mellitus self-management?
If effective, which facets of the peer model are most effective? Peer coaches will Undergo peer coach training.
Reach out to peer participants on a weekly/biweekly time frame to discuss self-management and goal setting.
Retain records of contact, topics discussed, and general notes on interactions. Researchers will compare differences in the frequency of contact, as well as how peer coaches were matched to peer participants to see if efficacy of the intervention is altered between groups.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Zoe M Taylor, MSPH
- Phone Number: 859-562-0757
- Email: Zoe.Taylor@uky.edu
Study Contact Backup
- Name: Brittany L Smalles, PhD
- Phone Number: 859-323-4916
- Email: Brittany.Smalls@uky.edu
Study Locations
-
-
Kentucky
-
Bowling Green, Kentucky, United States, 42101
- Recruiting
- Barren River Area Development District
-
Contact:
- Michelle Hines
- Phone Number: 270-306-4036
- Email: michelle@bradd.org
-
Hazard, Kentucky, United States, 41701
- Recruiting
- UK HealthCare
-
Contact:
- Kay Douthitt, MD
- Email: key.douthitt@uky.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age greater than or equal to 55 years
- Resident in Rural Kentucky
- Positive Diagnosis of Type 2 Diabetes Mellitus
- HbA1c greater than or equal to 7.5%
- Passing score on cognitive assessment administered by study personnel
- English Speaking
Exclusion Criteria:
- Age less than 55 years
- Not a resident of a Rural Kentucky County
- No Type 2 Diabetes Mellitus Diagnosis
- HbA1c under 7.5%
- Cognitive Impairment
- Non-english speaking
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Peer Participant Group A
Participants will self-select their peer coach and will receive contact once a week.
|
Peer participants will be contacted by peer coaches on a weekly basis.
|
Other: Peer Participant Group B
Participants will self-selected their peer coach and will receive contact every 2 weeks
|
Peer participants will be contacted by peer coaches on a bi-weekly basis
|
Other: Peer Participant Group C
Participants will be matched with a peer coach and will receive contact once a week
|
Peer participants will be contacted by peer coaches on a weekly basis.
|
Other: Peer Participant Group D
Participants will be matched with a peer coach and will receive contact every 2 weeks.
|
Peer participants will be contacted by peer coaches on a bi-weekly basis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants with change in A1c
Time Frame: Collected at Baseline, 3 month, and 6 month follow up.
|
Obtained using point of care assessment
|
Collected at Baseline, 3 month, and 6 month follow up.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diabetes Empowerment
Time Frame: Collected at Baseline, 3 month, and 6 month follow up.
|
"Attitudes Towards Diabetes- DES". 5 point scale ranging from 1 "Strongly Agree" to 5 "Strongly Disagree", where lower scores indicate greater feelings of empowerment.
|
Collected at Baseline, 3 month, and 6 month follow up.
|
Depression Scale
Time Frame: Collected at Baseline, 3 month, and 6 month follow up.
|
"Geriatric Depression Scale: Short Form" is a binary survey where participants can select "yes" or "no".
Each "yes" is a singular point, if a score >5 points it is suggestive about depression and warrant a follow-up comprehensive assessment.
A score of greater than or equal to 10 is almost always indicative of depression.
|
Collected at Baseline, 3 month, and 6 month follow up.
|
Problem Areas in Diabetes
Time Frame: Collected at Baseline, 3 month, and 6 month follow up.
|
"Problem Areas In Diabetes (PAID) Scale" a five point scale ranging from 0 "not a problem" to 4 "serious problem", where a higher score indicates more problems in diabetes management.
|
Collected at Baseline, 3 month, and 6 month follow up.
|
Diabetes Self-Management
Time Frame: Collected at Baseline, 3 month, and 6 month follow up.
|
Diabetes Self-Management Questionnaire (DSMQ) is a four point scale ranging from 0 "does not apply to me" to 3 "applies to me very much".
Higher scores indicate better diabetes management.
|
Collected at Baseline, 3 month, and 6 month follow up.
|
Social Network Scale
Time Frame: Collected at Baseline, 3 month, and 6 month follow up.
|
"Lubbens Social Network Scale - 6 (LSNS-6) is a five point scale ranging from "0" none to "5" nine or more.
Higher scores indicate greater amount of social support.
|
Collected at Baseline, 3 month, and 6 month follow up.
|
Quality of Life Index
Time Frame: Collected at Baseline, 3 month, and 6 month follow up.
|
"EuroQofL-5D" measures acts of daily living (ADL) on a five point scale ranging from 0 "no" problems to 5 "extreme" problems, where higher scores indicate lower ability to engage in ADL. "EuroQofL-5D" measures acts of daily living (ADL) on a five point scale ranging from 0 "no" problems to 5 "extreme" problems, where higher scores indicate lower ability to engage in ADL. "EuroQofL-5D" measures acts of daily living (ADL) on a five point scale ranging from 0 "no" problems to 5 "extreme" problems, where higher scores indicate lower ability to engage in ADL. "EuroQofL-5D" measures acts of daily living (ADL) on a five point scale ranging from 0 "no" problems to 5 "extreme" problems, where higher scores indicate lower ability to engage in ADL. |
Collected at Baseline, 3 month, and 6 month follow up.
|
Social Support
Time Frame: Collected at Baseline, 3 month, and 6 month follow up.
|
"MOS Social Support Survey" a five point scale ranging from 1 "none of the time" to 5 "all of the time" where higher scores indicate better social support. "MOS Social Support Survey" a five point scale ranging from 1 "none of the time" to 5 "all of the time" where higher scores indicate better social support. "MOS Social Support Survey" a five point scale ranging from 1 "none of the time" to 5 "all of the time" where higher scores indicate better social support. "MOS Social Support Survey" a five point scale ranging from 1 "none of the time" to 5 "all of the time" where higher scores indicate better social support. |
Collected at Baseline, 3 month, and 6 month follow up.
|
Acts of Daily Living
Time Frame: Collected at Baseline, 3 month, and 6 month follow up.
|
"Lawton-Brody Instrumental Activities of Daily Living Scale (L.A.D.L) is a binary where "0" is low functioning and "1" is high functioning.
Higher scores indicate higher functioning
|
Collected at Baseline, 3 month, and 6 month follow up.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 83904_1
- R01DK135885-01 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
Diabetes Foundation, IndiaNational Diabetes Obesity and Cholesterol FoundationRecruitingType 2 Diabetes Mellitus With ComplicationIndia
Clinical Trials on Peer Coach Training - Weekly
-
University of Alabama at BirminghamRecruitingHIV Infections | Opioid-Related Disorders | Pre-Exposure Prophylaxis (PrEP)United States
-
University of RochesterNational Heart, Lung, and Blood Institute (NHLBI)Enrolling by invitationCardiovascular DiseasesUnited States
-
VA Office of Research and DevelopmentCompletedChronic PainUnited States
-
Zhongda HospitalUnknownGlucose Metabolism Disorders | Metabolic Diseases | Endocrine System Diseases | DiabetesChina
-
Northwestern UniversityCompletedDepressionUnited States
-
University of California, San FranciscoAmerican Academy of Family PhysiciansCompleted
-
University of PennsylvaniaCompleted
-
The Miriam HospitalCompleted
-
University of PittsburghNot yet recruitingParaplegia | Wheelchair
-
VA Office of Research and DevelopmentRecruitingMultimorbidityUnited States